Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ceribell (CBLL) Research & Development (2023 - 2025)

Ceribell's Research & Development history spans 3 years, with the latest figure at $5.1 million for Q4 2025.

  • For Q4 2025, Research & Development rose 29.36% year-over-year to $5.1 million; the TTM value through Dec 2025 reached $19.1 million, up 41.15%, while the annual FY2025 figure was $19.1 million, 41.15% up from the prior year.
  • Research & Development reached $5.1 million in Q4 2025 per CBLL's latest filing, up from $5.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $5.1 million in Q4 2025 to a low of $2.3 million in Q3 2023.
  • Average Research & Development over 3 years is $3.8 million, with a median of $3.7 million recorded in 2024.
  • The largest YoY upside for Research & Development was 48.38% in 2025 against a maximum downside of 29.36% in 2025.
  • A 3-year view of Research & Development shows it stood at $2.7 million in 2023, then skyrocketed by 45.57% to $3.9 million in 2024, then rose by 29.36% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for CBLL's Research & Development are $5.1 million (Q4 2025), $5.0 million (Q3 2025), and $4.9 million (Q2 2025).